Now showing items 1-2 of 2

    • Nolan, Terry; Santolaya de Pablo, María Elena; de Looze, Ferdinandus; Marshall, Helen; Richmond, Peter; Henein, Sam; Rheault, Paul; Heaton, Ken; Perrett, Kirsten P.; Garfield, Hartley; Gupta, Anil; Ferguson, Murdo; D'Agostino, Diego; Toneatto, Daniela; O'Ryan, Miguel (Elsevier Ltd, 2019)
      Background: Data on duration of protection against invasive meningococcal disease post-vaccination with the recombinant, 4-component, meningococcal serogroup B vaccine (4CMenB) are limited. We evaluated bactericidal activity ...
    • Santolaya de Pablo, María Elena; O'Ryan Gallardo, Miguel; Valenzuela, María Teresa; Prado Jiménez, Valeria; Vergara, Rodrigo F.; Muñoz, Alma; Toneatto, Daniela; Graña, Gabriela; Wang, Huajun; Dull, Peter M. (Taylor & Francis, 2013)
      We previously demonstrated the immunogenicity and tolerability of the serogroup B meningococcal vaccine, 4CMenB (Bexsero®), in 11-17 y-olds randomized to receive 1, 2, or 3 doses at 1, 2, or 6 mo intervals. participants ...